LuVit D3

Quick links to important sections

LuVit D3

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of LuVit D3

Property Description
Active ingredient Colecalciferol (Vitamin D3)
Form Oral liquid/drops, capsules, or tablets
Pharmacological class Vitamin D Analogue / Fat-soluble vitamin
Common use Supporting bone strength and mineral balance
Origin Endogenous (skin synthesis) and Exogenous (supplement)

LuVit D3: Identity and Chemical Composition

The drug entity LuVit D3 is a medicinal preparation whose active ingredient is Colecalciferol, which is officially known as Vitamin D3. This compound is classified as a fat-soluble vitamin and a secosteroid prohormone, meaning its chemical structure is related to steroids, and it must be processed by the body to become fully active. Colecalciferol is the exact form of Vitamin D synthesized endogenously in the skin, but it is typically administered exogenously in LuVit D3 as a single-ingredient product to supplement the body's levels. LuVit D3 is primarily provided for oral administration in formats such as an oral liquid/drops suspended in an edible oil base or contained within oral capsules or tablets. This oily base is necessary to facilitate proper absorption due to the compound’s fat-soluble nature.


Classification and Core Physiological Role

LuVit D3 is categorized as a Vitamin D analogue designed to support the body’s mineral homeostasis. Pharmacological studies have clinically recognized that Colecalciferol is generally more effective at improving blood Vitamin D status compared to the structurally similar compound, Ergocalciferol (Vitamin D2).

The medication's fundamental purpose is centered on bone health; the body converts Colecalciferol into the active hormone Calcitriol, which then critically stimulates the absorption of calcium from the intestinal tract. By ensuring the proper availability and utilization of both calcium and phosphate, the medication's core benefit is to support the structural integrity and strength of bone tissue.

Regulatory References

  1. Cholecalciferol (Vitamin D3) Drug Information

What side effects are possible with LuVit D3?

Possible Side Effects and Safety Information

The safety profile for Colecalciferol (LuVit D3) is principally determined by its fundamental role in mineral homeostasis. The most significant adverse reactions documented in official regulatory sources relate to the maintenance of proper calcium balance, often associated with high or excessive exposure.


Adverse Reactions Classified by Frequency

Adverse reactions are grouped according to their incidence rate as defined in regulatory documents:

  • Uncommon (occurring in fewer than 1 in 100 patients):

    • Hypercalcaemia (elevated calcium levels in the blood).
    • Hypercalciuria (elevated calcium levels in the urine).
  • Rare (occurring in fewer than 1 in 1,000 patients):

    • Skin and subcutaneous disorders, including Pruritus (itching), Rash, and Urticaria (hives).

Reactions such as general Hypersensitivity reactions, including Angio-oedema and Laryngeal oedema, have been reported but are classified as Not Known frequency as their rate cannot be reliably estimated from available data.


Serious Adverse Reactions and Safety Constraints

The most serious outcomes are typically linked to sustained, high-level exposure, resulting in a condition known as Hypervitaminosis D. This may lead to long-term complications such as Nephrolithiasis (kidney stones) and Vascular and organ calcification due to chronic, high calcium concentrations.

Regulatory documents stipulate that the medicine is contraindicated (should not be used) in individuals who already have Hypercalcaemia or Hypervitaminosis D. Specific caution is noted for use in patients with severe renal impairment and those with conditions such as sarcoidosis, which can increase the risk of hypercalcaemia.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with LuVit D3 (Colecalciferol) is officially defined as Hypervitaminosis D, a condition primarily characterized by hypercalcaemia, which is an excessive concentration of calcium in the blood and urine. The documented manifestations listed in regulatory labeling include gastrointestinal effects such as nausea, vomiting, and anorexia, along with systemic symptoms like fatigue, headache, muscle weakness, polyuria (frequent urination), and polydipsia (increased thirst).

Severe or prolonged hypercalcaemia is officially described to cause systemic organ toxicity. This can lead to renal failure, nephrocalcinosis (kidney calcification), and dangerous cardiac arrhythmias. In isolated cases, extreme toxicity has been documented to result in coma or fatality. For patients who are pregnant, massive doses have been officially linked to severe fetal complications, including aortic stenosis syndrome in the newborn.

If an overdose is suspected, official regulatory guidance mandates the immediate withdrawal of LuVit D3 and all other calcium supplements. Immediate medical attention must be sought for any persistent or severe symptoms of intoxication, such as ongoing vomiting, severe confusion, or extreme thirst. Management is officially described as symptomatic and supportive; no specific antidote is known. Close medical supervision is required for monitoring serum calcium, phosphate, and renal function until levels normalize.

Therapeutic Uses of LuVit D3

LuVit D3 (Cholecalciferol) is commonly used across conditions involving episodic or fluctuating manifestations related to vitamin D deficiency or insufficiency and relevant in contexts involving heightened systemic burden. Cholecalciferol belongs to a class of medications called vitamin D analogs. This is applied across therapeutic domains where additional symptomatic support is needed. The compound is considered relevant for easing symptoms related to physical discomfort.

The therapeutic domains are relevant in conditions presenting with systemic or localized discomfort linked to organ-specific functional stress. It is commonly used across conditions involving episodic or fluctuating manifestations, and is applied in addressing conditions like rickets (in children), osteomalacia (softening of the bones in adults), and to support management of osteoporosis. This support contributes to improved comfort during periods of heightened symptoms.

Quick Fact: Symptoms related to physical discomfort (e.g., bone or muscle pain) are relevant when supportive symptom management is appropriate.

Regulatory References

  1. Cholecalciferol (Vitamin D3): MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use LuVit D3 (Colecalciferol)

The official eligibility profile for Colecalciferol is defined by formal regulatory classifications, strictly identifying populations where use is prohibited, restricted, or allowed under standard conditions.

Populations for whom use is Contraindicated

Absolute prohibitions prevent the use of LuVit D3 in patients diagnosed with Hypervitaminosis D (excessive Vitamin D), Hypercalcaemia (high calcium levels in the blood), and Hypercalciuria (high calcium levels in the urine). The medicine is also contraindicated in those with Hypersensitivity to the active ingredient or excipients, Nephrolithiasis (kidney stones), or Nephrocalcinosis.

Age- and Condition-Specific Restrictions

Category Regulatory Status
Severe Renal Impairment Not Recommended; severe kidney function loss prevents proper metabolism of Colecalciferol.
Children under 12 Years Not Recommended for many capsule/tablet or high-strength formulations. Adults and the elderly are generally approved for use.
Sarcoidosis Caution Required; this condition may increase the body's sensitivity and metabolism of Colecalciferol.
Pregnancy Restricted; use to treat deficiency is permitted, but high doses (e.g., above 4,000 IU/day) must be avoided due to documented risks associated with overdose.

Use in patients with non-severe renal impairment and during breastfeeding also requires caution and monitoring.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information outlines several categories of interacting substances that may alter the effects or blood levels of LuVit D3 (Cholecalciferol) or increase specific risks.


Medications Affecting LuVit D3 Exposure

  • Enzyme Inducers (e.g., Phenytoin, Barbiturates, Rifampicin): Concomitant use with these anticonvulsants or antituberculosis agents may increase the metabolism and reduce the therapeutic effect of LuVit D3, necessitating monitoring of Vitamin D levels.
  • Glucocorticoids (Systemic): These medicines can increase the metabolism and elimination of Vitamin D, also leading to a decrease in LuVit D3's effectiveness.
  • Absorption Inhibitors (e.g., Cholestyramine, Colestipol, Paraffin oil): Simultaneous administration of these ion exchange resins or certain laxatives impairs the gastrointestinal absorption of LuVit D3, potentially requiring specific timing separation requirements for administration.
  • Antifungal and Cytotoxic Agents (e.g., Actinomycin, Imidazole antifungals): These agents are documented to interfere with the body's conversion of LuVit D3 to its active form.

Increased Risk of Toxicity

  • Cardiac Glycosides (e.g., Digitalis): Use requires strict medical supervision as LuVit D3-induced hypercalcaemia may significantly increase the risk of digitalis toxicity and serious cardiac arrhythmias.
  • Thiazide Diuretics: These diuretics reduce calcium excretion in the urine. Co-administration increases the risk of hypercalcaemia, mandating regular monitoring of serum calcium levels.
  • Magnesium-Containing Products (e.g., Antacids): Taking high doses of LuVit D3 with magnesium-containing products should be avoided due to the potential for hypermagnesaemia.
  • Other Vitamin D Products: The content of all forms of Vitamin D in other products must be considered to prevent excessive intake and associated toxicity.

Mechanism of Action

Receptor Agonism and Gene Transcription Modulation

The drug's active form acts as an agonist for the Vitamin D Receptor (VDR), a nuclear receptor found in cells including the intestine and bone. Upon binding, the VDR complex directly modulates gene transcription by attaching to specific DNA sequences (VDREs). This genomic action regulates the production of proteins essential for mineral transport, such as Calbindin-D28k, initiating the mechanism. This differs from non-genomic mechanisms that interfere directly with channels or enzymes.


Regulation of Systemic Mineral Balance

The activated mechanism is central to maintaining calcium ( Ca^2+) and phosphate ( PO4^3-) homeostasis by influencing circulating concentrations. The resulting increase in transport proteins enhances the absorption of these minerals across the intestinal wall and promotes their reabsorption from the filtrate in the renal tubules. This effect ensures sufficient mineral substrate is available in the systemic circulation.


Influence on Skeletal Mineralization

The final step of the cascade focuses on bone tissue. The mechanism influences the activity of osteoblasts (bone-building cells) and facilitates the deposition of the circulating calcium and phosphate into the osteoid matrix to form hydroxyapatite crystals. This physiological process directly contributes to the formation of bone density and skeletal structural integrity.

Dosage and Administration Information

How LuVit D3 Is Used

LuVit D3 (Colecalciferol) is administered exclusively via the oral route, utilizing dosage forms such as capsules, tablets, or liquid drops. Proper use follows a structured protocol centered on maximizing absorption and aligning the dose with the specific therapy stage, as directed by official prescribing information.


Official Dosing and Administration Protocol

Use Parameter Regulatory Guidelines
Route of Administration Oral (swallowed).
Timing in Relation to Meals Must be taken with the main meal of the day to optimize absorption of the fat-soluble component.
Dosing Schedule Dual-Phase: A short-term, high-dose Treatment Phase (e.g., 50,000 IU once weekly for up to 10 weeks) followed by a Maintenance Phase (e.g., 800 IU to 2,000 IU daily).
Frequency Pattern Ranges from Daily (for maintenance) to Weekly or intermittent dosing (for deficiency treatment).
Liquid/Drop Preparation The oral solution must be measured using the calibrated dropper or syringe supplied by the manufacturer for dose accuracy.
Handling of Missed Dose If a daily or weekly dose is missed, take the next scheduled dose at the usual time; do not double the dose to compensate.
Specific Populations Pediatric doses are highly individualized and start lower (e.g., 400 IU daily for infants). No specific dose adjustment is generally required for hepatic impairment, but caution is advised in severe renal impairment.

This structured approach ensures that the administration of LuVit D3 aligns with regulatory guidelines for managing long-term mineral balance.

Recent Clinical Evidence

LuVit D3: Recent Clinical Evidence

This overview describes the types of research and general findings for Colecalciferol (LuVit D3) based on scientific and regulatory information, focusing on what studies have explored and what remains uncertain. It does not offer medical advice or recommendations.


Evidence for Treating Vitamin D Deficiency and Bone Mineralization Disorders

LuVit D3 was studied for its role in the context of low vitamin D levels, known as deficiency or insufficiency. The research base is consistent, utilizing Randomized Controlled Trials (RCTs) and systematic reviews. Studies have examined changes in the key blood measurement, 25-hydroxyvitamin D [25(OH)D] levels, and monitored the evolution of physical symptoms associated with rickets and osteomalacia. Findings describe patterns where treatment was associated with measurements indicating increased 25(OH)D levels. Regulatory reviews indicate that the evidence for this indication is supported by a large volume of historical clinical and scientific reports. Scientific consensus remains uncertain regarding the precise blood level that universally defines sufficiency.


Research on Supportive Use in Osteoporosis and Fracture Prevention

Large-scale clinical trials and comprehensive meta-analyses have evaluated LuVit D3, often alongside calcium, for its supportive role in managing osteoporosis and exploring outcomes related to bone sequelae. Research examined clinical outcomes such as the rate of falls and the incidence of fractures. Data show patterns related to lower observed rates of falls and fractures was observed in some studies, but the findings were mixed across the entire body of evidence. A key limitation is that most research is derived from combination therapy, making the isolated contribution of Colecalciferol difficult to fully determine.


Evidence in Specific Groups and Remaining Uncertainty

Research was studied most frequently for children and adolescents and older adults in fracture prevention trials. Evidence is limited for populations with complex comorbidities. The overall evidence quality varies across studies, leading to inconsistent results, particularly for the fracture prevention outcome. Long-term effects regarding the durability of corrected vitamin D levels are not fully established, and researchers continue to explore whether specific subgroups show different patterns of measured changes.

Key Studies & References

  1. Cholecalciferol (Vitamin D3) - MedlinePlus Drug Information
  2. Vitamin D: NICE guideline [NG24]

Frequently Asked Questions (FAQ)

Common questions about LuVit D3 (FAQ)


Q: Is LuVit D3 the same as just taking a regular Vitamin D supplement?

A: LuVit D3 contains the active ingredient Colecalciferol (Vitamin D3), which is the natural form of Vitamin D produced by the skin. Most dietary supplements contain either this form (D3) or Ergocalciferol (D2). Therefore, LuVit D3 is considered a medicinal preparation of Vitamin D3.


Q: How quickly should I expect to feel a difference after starting LuVit D3?

A: LuVit D3 (Colecalciferol) does not take effect immediately, as the body must process it into its active hormone form (Calcitriol). Regulatory reviews and studies suggest that levels of Vitamin D (25(OH)D) often begin to rise within approximately 4 weeks, with many patients reaching target levels after 8 to 12 weeks of consistent therapy. Individual responses may vary.


Q: Can I take LuVit D3 every day?

A: Daily dosing is a standard administration schedule described in official prescribing information for Colecalciferol. While the specific frequency and amount depend on the treatment phase, daily use is commonly indicated for long-term maintenance therapy.


Q: What happens if I miss a dose of LuVit D3?

A: The official product information instructs that if a dose is missed, the next scheduled dose should be taken at the usual time. Patients are specifically warned not to take a double dose to compensate for a single missed one.


Q: Are there any common side effects people report when taking LuVit D3?

A: Regulatory documents primarily list less common adverse reactions like hypercalcaemia (high blood calcium) and rash. While official tables don't specify common effects, mild stomach discomfort or headache may be reported during initial adjustment. Any persistent or severe effects should be discussed with a qualified healthcare professional.


Q: Does alcohol consumption affect how LuVit D3 works?

A: Official patient information states that there are typically no contraindications regarding consuming alcohol while taking Colecalciferol. Any concerns about alcohol use and your medication should be discussed with a doctor.


Q: Does LuVit D3 need to be taken with food?

A: Yes. Official prescribing information indicates that LuVit D3 should be taken with a meal. Because the active ingredient is fat-soluble, taking it with the main meal of the day helps the body absorb the medicine most effectively.


Q: What type of food helps the absorption of LuVit D3?

A: LuVit D3 is fat-soluble and is best absorbed when taken with food that contains fat. Official guidance suggests taking it with the main meal of the day for optimal absorption.


Q: Is LuVit D3 safe for children or teenagers?

A: LuVit D3 is indicated for deficiency treatment in adolescents generally from 12 years of age. High-strength or certain formulations are not recommended for those under 12. Dosing for children under 12 must be highly individualized and determined by a healthcare provider.


Q: Do older adults need a different dose of LuVit D3?

A: No specific dose adjustment is generally required for older adults unless they have severe kidney impairment or other risk factors. Older adults are typically included in the standard adult dosing schedules.


Q: What are the long-term effects of taking LuVit D3?

A: During long-term therapy, monitoring of serum calcium levels and kidney function is typically recommended. Chronic, excessive intake can lead to serious risks such as Hypervitaminosis D, which may cause kidney stones and calcification of organs due to prolonged high calcium levels.


Q: Can I take LuVit D3 if I have kidney stones?

A: Official product information indicates that LuVit D3 is contraindicated (should not be used) in patients with a history of Nephrolithiasis (kidney stones) or related conditions like Nephrocalcinosis.


Q: Can LuVit D3 improve my immune system?

A: While the primary formal indication for LuVit D3 is supporting bone health and correcting deficiency, Vitamin D is recognized by health authorities for its essential role in many physiological processes, including supporting normal immune system function.


Q: Why is LuVit D3 sometimes prescribed instead of other Vitamin D products?

A: LuVit D3 contains Colecalciferol (Vitamin D3), the form naturally produced by the skin. Pharmacological studies suggest that Colecalciferol is generally more effective at raising and sustaining blood Vitamin D levels compared to Ergocalciferol (Vitamin D2).


Q: How long does LuVit D3 stay in your system?

A: Vitamin D is fat-soluble, and its active form has a relatively long half-life. This means it remains in the body for an extended period, which supports the flexible dosing schedules, ranging from daily to weekly or intermittent administration, described in official use.


Q: Why do some people experience dry mouth when taking Vitamin D supplements like LuVit D3?

A: Dry mouth is not listed as a side effect with a known frequency. However, symptoms of Hypercalcaemia (excessively high calcium levels) that can occur with high-dose use include excessive thirst (polydipsia) and frequent urination, which may contribute to a feeling of dry mouth.


Q: Is LuVit D3 a steroid?

A: No, LuVit D3 is not a conventional steroid drug. Its active component, Colecalciferol, is chemically classified as a secosteroid prohormone, meaning its structure is related to steroids, and it acts as a precursor to the active hormone Calcitriol.


Q: Is it normal to feel a bit dizzy when first starting LuVit D3?

A: Dizziness is not listed as a common or uncommon side effect in official reports. If symptoms such as dizziness, confusion, or drowsiness are observed, they may indicate elevated calcium levels (hypercalcaemia) and require consultation with a healthcare provider.


Q: Is LuVit D3 gluten-free or suitable for vegans?

A: The active ingredient Colecalciferol is often derived from lanolin (sheep's wool fat), which may make certain products unsuitable for vegans. Suitability regarding gluten-free or vegan status depends entirely on the specific product formulation's excipients (inactive ingredients). Patients should review the official ingredients list (excipients) in the product’s leaflet for confirmation on gluten-free or vegan status.


Q: Does LuVit D3 interact with herbal supplements like St. John's Wort?

A: Official documents warn against certain medicines that act as enzyme inducers because they can increase the metabolism of Vitamin D and reduce its therapeutic effect. Since St. John's Wort is a known potent enzyme inducer, co-administration with it requires medical supervision.


Q: How often do most people need to have their Vitamin D levels checked while on LuVit D3?

A: Follow-up blood level measurements, specifically 25(OH)D levels, are often recommended approximately three to four months after starting maintenance therapy to confirm that the patient has reached the desired level.


Q: Are the LuVit D3 side effects different for men and women?

A: Regulatory safety information does not generally describe different side effect profiles for men and women for Colecalciferol. The most significant adverse effects, such as hypercalcaemia, relate to mineral balance, which is managed similarly across both populations.


Q: What happens if I accidentally take two doses of LuVit D3 close together?

A: Accidentally taking an extra dose increases the risk of overdose and excessive calcium levels (Hypercalcaemia). If an acute overdose is suspected, a healthcare professional should be contacted immediately for monitoring of calcium levels, as symptoms can include nausea, vomiting, and confusion.


Q: Why do some people take LuVit D3 in very large, infrequent doses?

A: High-dose, infrequent regimens (e.g., weekly or monthly) are often utilized as a short-term Treatment Phase or 'loading dose'. This is done to rapidly and effectively correct a confirmed severe Vitamin D deficiency before the patient transitions to a standard daily dose.


Q: What should I do if I think LuVit D3 is causing me stomach issues?

A: If minor stomach issues such as pain or nausea are experienced, public safety information suggests taking the medication with food. If the problem persists or is severe, consulting a healthcare provider is appropriate.


Q: Can I crush or split my LuVit D3 tablet/capsule?

A: The ability to crush or split the medicine depends on the specific product formulation. While some solid forms may be permitted, others are designed to be swallowed whole. Patients should always refer to the specific patient information leaflet for their product, as it contains instructions for the method of administration.


Q: Is there a generic version of LuVit D3 available?

A: Yes. The active ingredient, Colecalciferol, is widely available under many different brand names and is also sold as a generic product in various strengths and formulations (e.g., drops, capsules, tablets).


Q: Why is Vitamin D deficiency so common, and how does LuVit D3 help?

A: Vitamin D deficiency is common because many people globally have inadequate dietary intake and/or insufficient exposure to sunlight (UVB). LuVit D3 helps by supplying the external Colecalciferol necessary to correct the deficiency and restore healthy mineral balance and bone support.


Q: Can LuVit D3 affect laboratory test results?

A: Yes. LuVit D3 therapy requires laboratory monitoring of serum calcium, urinary calcium, and renal function. The medication is intended to change Vitamin D (25(OH)D) levels, and excessive intake can lead to high, abnormal test results for both calcium and Vitamin D.


How should LuVit D3 be stored and disposed of?

How to Store and Dispose of LuVit D3?

The storage and disposal of LuVit D3 (colecalciferol) must adhere strictly to the conditions documented in official regulatory labeling.


Storage Requirements

The medicine must be stored below 25°C (77°F) or within the range of 15 C to 30 C (59 F to 86 F), depending on the specific product formulation. It must be protected from light and moisture and stored in the original package with the container tightly closed.

  • Do not refrigerate or freeze liquid formulations.
  • Discard some oral solutions after a defined period (e.g., 60 days) following first opening.

Disposal and Safety

It is mandatory to keep this medicine out of the sight and reach of children.

Disposal instructions mandate that the product must not be thrown away via wastewater or household waste, and any unused medicine or waste material must be disposed of in accordance with local requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of LuVit D3 found in:

A-Z Index: